Strategy and targets
Sustainable profitable growth as an expert in photonics
Global megatrends offer growth opportunities for Jenoptik
With the new Agenda 2025 “MORE VALUE” Jenoptik is focusing on sustainable profitable growth in photonic core markets
By focusing on photonic growth markets, we want to develop Jenoptik into a globally positioned photonics company. We have largely completed this transformation, creating strong growth platforms. For the remainder of the strategy period, our main priorities for the implementation of Agenda 2025 are organic growth, operational excellence, innovation, and customer focus.
The core of the "More Value" agenda is to focus Jenoptik's technological expertise on the three high-growth future markets of semiconductor & electronics, life science & medical technology as well as smart mobility. As an “enabler”, the company can create significant added value (“More Value”) for all stakeholders – e.g. customers, employees, and shareholders – with its photonic solutions, aiming for above-average growth and increasing profitability. For us, entrepreneurial activity is closely linked to our commitment to the environment and society.
Goals 2026
Forecasted revenue
~ 1.2 bn euros
EBITDA margin
21-22 %
ROCE > WACC
More information on our Agenda 2025 "MORE VALUE" is available in the presentation from the 2021 Capital Markets Day.
Objectives of Agenda 2025 “MORE VALUE”
- Transform Jenoptik into a globally leading pure photonics group
- Focus on three highly attractive growth markets: semiconductors/electronics, life sciences/medical technology and smart mobility
- Accelerate organic and non-organic growth
- Further increase profitability
- Strengthen financial firepower for organic growth and further acquisitions
Our photonic core markets
Semiconductors & Electronics
We want to support the next level of digitalization through photonic innovations and be recognized worldwide as a leading provider of application-specific optical testing and measurement solutions for high-end electronic products.
Life Science & Medical Technology
As one of the leading photonic OEM partners in the life science/medical technology sector, we want to contribute to improving the lives of millions of people around the world.
Smart Mobility
We aim to become a global, full-service provider that provides technology and services for mobility infrastructures with an innovative product portfolio and generates at least 50% recurring revenue.
Video: Enabling the amazing
In implementing our Agenda 2025 “MORE VALUE,” we rely on:
Digitization and innovation
As an innovative, high-tech company, it is essential for Jenoptik to identify future customer needs and trends at an early stage in order to derive corresponding technology and product developments from them. With our know-how and innovative products, Jenoptik, as an enabler, makes an important contribution to overcoming societal challenges and enables our customers to contribute more efficiently and sustainably to more resource conservation and climate protection.
Sustainability strategy
Sustainability is an integral part of our corporate strategy. Our sustainability targets are taken into account in the Executive Board remuneration and are incorporated into our group financing.
Operational excellence
With the introduction of the new Jenoptik Business System, we are supporting the implementation of our Agenda 2025.
Human Resources Management
The commitment and know-how of our employees worldwide is the key to Jenoptik’s success and sustainable growth.
Guidance
Due to amongst other things a change in product mix the Group’s EBITDA margin improved to approximately 22 percent in the first nine months of 2026 compared with 17.5 percent in the prior year, based on preliminary figures. Therefore, the Executive Board now expects an EBITDA margin of around 22 percent also for the full fiscal year 2026 (previously 20 to 21 percent).
Revenue growth in the current year is anticipated by the Executive Board to be unchanged between 5 and 9 percent compared with the prior year.The outlook for 2026 remains affected by significant market uncertainties due to macroeconomic and political developments that are difficult to predict.
Despite the significant decline in the first half of 2026, the Executive Board anticipates that capital expenditure will be slightly below the previous year’s level of 77.4 million euros for the full year. In particular, capacity for optics at the Jena site is set to be expanded.
This forecast is subject to the political and economic conditions not deteriorating. Possible changes to the portfolio are not taken into account in this forecast.
as at October 2026
